TxCell S.A. | |
Stock Exchange | Euronext Paris |
EPS |
EUR0.56 |
Market Cap |
EUR56.25 M |
Shares Outstanding |
23.2 M |
Public Float |
11.02 M |
Address |
Les Cardoulines HT1 Valbonne-Sophia Antipolis Rhone-Alpes 06560 France |
Employees | - |
Website | http://www.txcell.com/index.php/fr |
Updated | 09/14/2018 |
TxCell SA is a biotechnology company. The company engages in the research and development of cellular immunotherapy for chronic inflammatory and autoimmune diseases. Its pipeline consists of Ovasave, col treg, lupus, transplantation and car treg dermatology. |